Literature DB >> 22369187

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain.

Greg L Plosker1, Katherine A Lyseng-Williamson.   

Abstract

Buprenorphine lower-dose (5, 10 and 20 μg/h) transdermal patches, which are administered once every 7 days, are indicated in the management of chronic non-malignant pain. This review focuses on the labelling of this formulation (BuTrans®) in the EU. The analgesic efficacy of transdermal buprenorphine in patients with osteoarthritis of the hip and/or knee has been demonstrated to be equivalent to sublingual buprenorphine, noninferior to prolonged-release tramadol and generally superior to a matching transdermal placebo patch. When used together with regularly scheduled oral paracetamol (acetaminophen), transdermal buprenorphine was noninferior to codeine plus paracetamol. Transdermal buprenorphine has also shown analgesic efficacy in patients with chronic non-malignant pain of various causes.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22369187     DOI： 10.2165/11208360-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


  16 in total

Review 1.  Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis.

Authors:  Catherine Munera; Margaret Drehobl; Nelson E Sessler; Craig Landau
Journal:  J Opioid Manag       Date:  2010 May-Jun

3.  [Application of a seven-day buprenorphine transdermal patch in multimorbid patients on long-term ibuprofen or diclofenac].

Authors:  K Böhme; B Heckes; K Thomitzek
Journal:  MMW Fortschr Med       Date:  2011-01-13

4.  Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase.

Authors:  Allan Gordon; Denis Callaghan; Donald Spink; Christian Cloutier; Peter Dzongowski; William O'Mahony; Duncan Sinclair; Saifudin Rashiq; Norm Buckley; Geoffrey Cohen; James Kim; Aline Boulanger; Paula S Piraino; John Eisenhoffer; Zoltan Harsanyi; Andrew C Darke; Kenneth J Michalko
Journal:  Clin Ther       Date:  2010-05       Impact factor: 3.393

5.  Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.

Authors:  Allan Gordon; Saifudin Rashiq; Dwight E Moulin; Alexander J Clark; André D Beaulieu; John Eisenhoffer; Paula S Piraino; Patricia Quigley; Zoltan Harsanyi; Andrew C Darke
Journal:  Pain Res Manag       Date:  2010 May-Jun       Impact factor: 3.037

6.  Universal precautions in pain medicine: a rational approach to the treatment of chronic pain.

Authors:  Douglas L Gourlay; Howard A Heit; Abdulaziz Almahrezi
Journal:  Pain Med       Date:  2005 Mar-Apr       Impact factor: 3.750

Review 7.  Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.

Authors:  Hans G Kress
Journal:  Eur J Pain       Date:  2008-06-24       Impact factor: 3.931

8.  Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Authors:  Roger Chou; Gilbert J Fanciullo; Perry G Fine; Jeremy A Adler; Jane C Ballantyne; Pamela Davies; Marilee I Donovan; David A Fishbain; Kathy M Foley; Jeffrey Fudin; Aaron M Gilson; Alexander Kelter; Alexander Mauskop; Patrick G O'Connor; Steven D Passik; Gavril W Pasternak; Russell K Portenoy; Ben A Rich; Richard G Roberts; Knox H Todd; Christine Miaskowski
Journal:  J Pain       Date:  2009-02       Impact factor: 5.820

9.  Buprenorphine induces ceiling in respiratory depression but not in analgesia.

Authors:  A Dahan; A Yassen; R Romberg; E Sarton; L Teppema; E Olofsen; M Danhof
Journal:  Br J Anaesth       Date:  2006-03-17       Impact factor: 9.166

10.  Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.

Authors:  Craig J Landau; William D Carr; Albert J Razzetti; Nelson E Sessler; Catherine Munera; Steven R Ripa
Journal:  Clin Ther       Date:  2007-10       Impact factor: 3.393
View more
  7 in total

Review 1.  Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.

Authors:  Mellar P Davis; Gavril Pasternak; Bertrand Behm
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

2.  Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal Surgeries.

Authors:  Zia Arshad; Ravi Prakash; Shefali Gautam; Sanjeev Kumar
Journal:  J Clin Diagn Res       Date:  2015-12-01

3.  Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study.

Authors:  Mick Serpell; Shiva Tripathi; Sabine Scherzinger; Sònia Rojas-Farreras; Alexander Oksche; Margaret Wilson
Journal:  Patient       Date:  2016-02       Impact factor: 3.883

4.  Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain.

Authors:  Philip G Conaghan; Michael Serpell; Paula McSkimming; Rod Junor; Sara Dickerson
Journal:  Patient       Date:  2016-08       Impact factor: 3.883

5.  Efficacy of transdermal buprenorphine patch on post-operative pain relief after elective spinal instrumentation surgery.

Authors:  Saikat Niyogi; Pratibha Bhunia; Jisnu Nayak; Sankari Santra; Amita Acharjee; Indrani Chakraborty
Journal:  Indian J Anaesth       Date:  2017-11

6.  Work-related outcomes in randomized, double blind, placebo-controlled trials in osteoarthritis - are they adequately reported in journal publications? A systematic review.

Authors:  Daniel Sowah; Flora Balat; Sebastian Straube
Journal:  J Occup Med Toxicol       Date:  2018-10-20       Impact factor: 2.646

7.  Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl patch in management of postoperative pain after arthroscopic lower limb surgery: A randomized controlled trial.

Authors:  Hariom Khandelwal; Anoop Negi; Nishith Govil; Ashutosh Singh; Kumar Parag; Bharat Bhushan Bhardwaj
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.